These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8336336)

  • 1. Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus.
    Ternansky RJ; Draheim SE; Pike AJ; Bell FW; West SJ; Jordan CL; Wu CY; Preston DA; Albron W; Kasher JS
    J Med Chem; 1993 Jul; 36(14):1971-6. PubMed ID: 8336336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties.
    Ishikawa T; Matsunaga N; Tawada H; Kuroda N; Nakayama Y; Ishibashi Y; Tomimoto M; Ikeda Y; Tagawa Y; Iizawa Y; Okonogi K; Hashiguchi S; Miyake A
    Bioorg Med Chem; 2003 May; 11(11):2427-37. PubMed ID: 12735989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on beta-lactam antibiotics. XIX. Structure-activity relationships of cephalosporins having a thiadiazolylthiomethyl group at the C-3 side chain.
    Inamoto Y; Goto J; Sakane K; Kamimura T; Takaya T
    J Antibiot (Tokyo); 1991 May; 44(5):507-16. PubMed ID: 2061194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546).
    Glinka T; Huie K; Cho A; Ludwikow M; Blais J; Griffith D; Hecker S; Dudley M
    Bioorg Med Chem; 2003 Feb; 11(4):591-600. PubMed ID: 12538024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on novel 3-isoxazolylvinyl-cephalosporins: II. Synthesis and biological activity of 7-[2-(2-aminothiazol-4-yl)-2-hydroxy-iminoacetamido] derivatives.
    Choi KI; Cha JH; Pae AN; Cho YS; Kim Y; Chang MH; Park SH; Park SY; Kim D; Jeong DY; Kim YH; Kong JY; Koh HY
    J Antibiot (Tokyo); 1998 Dec; 51(12):1122-5. PubMed ID: 10048574
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel cephalosporins 1. Synthesis of 3-benzothiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):546-50. PubMed ID: 10908120
    [No Abstract]   [Full Text] [Related]  

  • 10. SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephems.
    Glinka TW; Cho A; Zhang ZJ; Ludwikow M; Griffith D; Huie K; Hecker SJ; Dudley MN; Lee VJ; Chamberland S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1045-52. PubMed ID: 11132949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):551-5. PubMed ID: 10908121
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationships of 2-thioisocephem against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Akagi H; Yasui M; Otani T
    J Antibiot (Tokyo); 1995 Aug; 48(8):901-3. PubMed ID: 7592041
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and anaerobic activity of novel 1-carba-1-dethiacephalosporins.
    Ternansky RJ; Jordan CL; Eudaly JA; Kasher JS
    J Med Chem; 1993 Aug; 36(16):2332-4. PubMed ID: 8360877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T; Tsushima M; Ishii T; Atsumi K; Tamura A
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MRSA cephems. Part 3: additional C-7 acid derivatives.
    Springer DM; Luh BY; Goodrich JT; Bronson JJ
    Bioorg Med Chem; 2003 Jan; 11(2):281-91. PubMed ID: 12470721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of a series of new parenteral optically active 3-[[(N-alkylpyridinium-4'-yl)thio]methyl]-2-oxaisocephems.
    Tsubouchi H; Tsuji K; Yasumura K; Matsumoto M; Shitsuta T; Ishikawa H
    J Med Chem; 1995 Jun; 38(12):2152-7. PubMed ID: 7783146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1053-70. PubMed ID: 11132950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives.
    Springer DM; Luh BY; Bronson JJ
    Bioorg Med Chem Lett; 2001 Mar; 11(6):797-801. PubMed ID: 11277523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial synthesis through disulfide exchange: discovery of potent psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA).
    Nicolaou KC; Hughes R; Pfefferkorn JA; Barluenga S; Roecker AJ
    Chemistry; 2001 Oct; 7(19):4280-95. PubMed ID: 11686609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis and biological characteristics of new orally active cephems.
    Ternansky RJ; Jordan CL; Bell FW; Skaggs TG; Kasher JS
    J Antibiot (Tokyo); 1993 Dec; 46(12):1897-900. PubMed ID: 8294250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.